期刊
OPHTHALMOLOGICA
卷 241, 期 4, 页码 220-225出版社
KARGER
DOI: 10.1159/000495623
关键词
Diabetic macular edema; Treat-and-extend regimen; Anti-VEGF; Ranibizumab; Aflibercept
Purpose: To evaluate real-life outcomes in treatment-naive patients with diabetic macular edema (DME) treated with anti-vascular endothelial growth factor (VEGF) agents using a treat-and-extend regimen without a fixed loading phase. Methods: Best-corrected visual acuity (BCVA) and central retinal thickness (CRT) measured using optical coherence tomography at baseline and after 1 year of treatment, intervals and number of injections were analyzed. Subgroup analysis was performed to compare anatomical and functional outcomes between patients receiving ranibizumab or aflibercept. Results: Seventy-five eyes of 61 patients met the inclusion criteria and had follow-up for 1 year. Baseline BCVA and CRT were 68.1 +/- 13.2 letters and 424 +/- 135 mu m, retrospectively. After 1 year, there was a significant mean gain in BCVA of + 5.8 +/- 7.4 letters (paired t test: p < 0.0001) and a significant decrease in mean CRT of -117 +/- 134 mu m (paired t test: p < 0.0001). The mean number of anti-VEGF injections was 10.0 +/- 1.6 (range 6-12). The mean maximum interval between injections was 8.5 +/- 2.9 weeks (range 4-14) and the mean interval 6.0 +/- 1.2 weeks (range 4.1-8.9). 96% of eyes could be extended after a mean of 5.3 injections and 17% of patients could be extended before reaching a formal loading dose of 3 injections. Subgroup analysis did not reveal any differences in outcomes between patients treated with ranibizumab or aflibercept. Subretinal fluid at baseline was associated with better BCVA gain after 1 year (stepwise forward regression analysis, p = 0.003). Conclusion: Our results suggest that not all patients with DME require a fixed loading phase when initiating anti-VEGF treatment. Finding anatomical predictors to identify this subgroup of patients would help to reduce treatment burden and optimize clinical outcomes. (C) 2019 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据